Sumitomo Mitsui Trust Group
ALMR

Sumitomo Mitsui Trust Group’s Alamar Biosciences ALMR Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
+56,452
New +$1.28M ﹤0.01% 840

Other funds holding ALMR

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group's ALMR Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 56,452 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #840 among its holdings.

9 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 56,452 shares of Alamar Biosciences worth $1.53M as of Q2 2026.
  • Alamar Biosciences was a new Sumitomo Mitsui Trust Group position in Q2 2026.
  • Alamar Biosciences made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #840 holding.
  • 9 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.